Alnylam Pharmaceuticals, Inc.

MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

15,466

Value ($000)

6,150

Weight

0.1%

2013 Q4 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	6,150	0.1%	15,466	12/31/2025
2025 Q3	10/31/2025	6,980	0.1%	15,307	9/30/2025
2025 Q2	7/29/2025	5,200	0.1%	15,946	6/30/2025
2025 Q1	5/9/2025	3,684	0.0%	13,644	3/31/2025
2024 Q4	2/5/2025	415	0.0%	1,763	12/31/2024
2024 Q3	11/6/2024	529	0.0%	1,924	9/30/2024
2024 Q2	8/9/2024	369	0.0%	1,519	6/30/2024
2024 Q1	5/2/2024	227	0.0%	1,519	3/31/2024
2023 Q4	1/26/2024	291	0.0%	1,519	12/31/2023
2023 Q3	11/9/2023	299	0.0%	1,687	9/30/2023
2023 Q2	8/11/2023	320	0.0%	1,687	6/30/2023
2023 Q1	5/4/2023	327	0.0%	1,633	3/31/2023
2022 Q4	2/10/2023	388	0.0%	1,633	12/31/2022
2022 Q3	11/8/2022	342	0.0%	1,710	9/30/2022
2021 Q1	5/13/2021	263	0.0%	1,863	3/31/2021
2020 Q4	2/12/2021	250	0.0%	1,920	12/31/2020
2020 Q3	11/13/2020	295	0.0%	2,028	9/30/2020
2020 Q2	8/6/2020	300	0.0%	2,028	6/30/2020
2020 Q1	5/11/2020	164	0.0%	1,503	3/31/2020
2019 Q4	2/11/2020	173	0.0%	1,503	12/31/2019
2014 Q2	8/7/2014	2,640	0.1%	41,792	6/30/2014
2014 Q1	5/9/2014	2,976	0.1%	44,322	3/31/2014
2013 Q4	2/5/2014	3,430	0.1%	53,322	12/31/2013